SCHEMBL3352988

SCHEMBL3352988

N[C@H]1CCCC[C@H]1n1ccc2ccc([N+](=O)[O-])cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 1/20 0.43
HTR7 P34969 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.38
HSP90AA1 P07900 1/20 0.38
ALDH1A1 P00352 3/20 0.37
MAPT P10636 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
RAB9A P51151 2/20 0.37
POLB P06746 2/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 2/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
SLC18A3 Q16572 2/20 0.36
KMT2A Q03164 1/20 0.36
CHRNB4 P30926 4/20 0.36
CHRNA3 P32297 4/20 0.36
GAA P10253 1/20 0.35
RIPK1 Q13546 1/20 0.35
NOS3 P29474 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3352991 1.00 CDC7 (0.43) CDC7HTR7SIRT2HSP90AA1ALDH1A1
SCHEMBL3358552 0.81 HTR7 (0.45) CDC7HTR7SIRT2HSP90AA1ALDH1A1
SCHEMBL3353526 0.80 CDC7 (0.43) CDC7HTR7SIRT2ALDH1A1MAPT
SCHEMBL3357611 0.80 CDC7 (0.43) CDC7HTR7SIRT2ALDH1A1MAPT
SCHEMBL3357757 0.77 NPC1 (0.47) CDC7HTR7SIRT2HSP90AA1ALDH1A1
SCHEMBL13537457 0.76 NOS3 (0.35) NOS3NOS1NOS2
SCHEMBL3353782 0.75 ALDH1A1 (0.42) CDC7HTR7SIRT2ALDH1A1LMNA
SCHEMBL3359093 0.75 ALDH1A1 (0.41) CDC7HTR7SIRT2ALDH1A1MAPT
SCHEMBL3352450 0.74 HTR7 (0.45) CDC7HTR7MAPTPOLBNOS3
SCHEMBL3353280 0.74 HTR7 (0.53) CDC7HTR7MAPTNOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2141163-A1 Substituted thiazolidinones, their production and utilisation as medicine Bayer Schering Pharma AG (DE) 2010-01-06 EP disclosed